QGEN WeeklyNYSE:QGEN weekly gave a bullish engulfing at the 5 and 20 EMA crossover along with MACD crossing up. This is after a triple bottom process around $46.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.37 EUR
80.75 M EUR
1.91 B EUR
214.41 M
About Qiagen N.V.
Sector
Industry
CEO
Thierry Bernard
Website
Headquarters
Venlo
Founded
1996
ISIN
NL0015002CX3
FIGI
BBG00HMXV475
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Qiagen NV 🧙Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the bal
QGEN (Qiagen N.V) - Bullish quarterly outlookQiagen N.V
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Analysis/Commentary
Strong EPS and Sales Growth Y-on-Y
Based on the stu
The Perception of QIAGEN DailyHello traders, QIAGEN is in a bullish push with sellers rejecting a buy candle and low bull volume. On the TIMEFRAME 30 15 Min a bull hammer move and in the 5 1 Min is in bullish continuity. Great likelihood of starting on the next high which corresponds to the middle of the median. And if the buyer
Great Look for QGENLoving this setup. QGEN has struggled with this level for over a year. Recently it has consolidated with very tight price action and low volume at the highs. Volume has started to come in over the last two days as it looks to make a run for it. A good swing trade candidate. A move below $41 would ha
Shot in the darkThis stock has a ton of positive hype surrounding it because of the 'rona. Nonetheless, the chart screams institutional liquidation to me. This is a gut feeling and I could easily be wrong a hundred fold. Something doesn't fit right and makes me I'm painting a picture in my head where institutional
Hi my name is: QiagenHello People,
Qiagen should create a normal flat. Therfore the wave C is coming an I wait for it.
May the foce be with you.
QIAGEN NV (QGEN) - GAP-FILL TRADEEntry Point: When price crosses above 50 DMA (blue line). This allows prices to take over 50 Week MA and 20 Month MA first.
Profit Taking: Around $40.50 when gap about to close
Stop Loss: When price crosses below 20 DMA to minimize heavy loss. For me, I will exit when price crosses below the support
Qiagen NV Bullish perspective Coronavirus Stock $qgenQGEN announced the shipping of its latest QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation purposes. The latest test kit helps detect the novel coronavirus SARS-CoV-2, thus adding rapid Sample to Insight syndromic testing to the company’s molecular testing so
Textbook SeahorseCouldn't ask for a better seahorse.
SWOOP-bust.
Where else you gonna put your offspring?
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
A3L06J
QIAGEN 24/31 CVYield to maturity
2.87%
Maturity date
Sep 10, 2031
QGEN5328376
QIAGEN N.V. 0.0% 17-DEC-2027Yield to maturity
1.74%
Maturity date
Dec 17, 2027
See all QGE3 bonds
Related stocks
Frequently Asked Questions
The current price of QGE3 is 37.07 EUR — it has decreased by −0.46% in the past 24 hours. Watch QIAGEN NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange QIAGEN NV stocks are traded under the ticker QGE3.
QGE3 stock has risen by 1.59% compared to the previous week, the month change is a 3.35% rise, over the last year QIAGEN NV has showed a −17.90% decrease.
We've gathered analysts' opinions on QIAGEN NV future price: according to them, QGE3 price has a max estimate of 48.45 EUR and a min estimate of 37.00 EUR. Watch QGE3 chart and read a more detailed QIAGEN NV stock forecast: see what analysts think of QIAGEN NV and suggest that you do with its stocks.
QGE3 reached its all-time high on Jan 28, 2025 with the price of 45.15 EUR, and its all-time low was 35.38 EUR and was reached on Mar 5, 2025. View more price dynamics on QGE3 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
QGE3 stock is 1.27% volatile and has beta coefficient of 0.56. Track QIAGEN NV stock price on the chart and check out the list of the most volatile stocks — is QIAGEN NV there?
Today QIAGEN NV has the market capitalization of 8.06 B, it has increased by 0.95% over the last week.
Yes, you can track QIAGEN NV financials in yearly and quarterly reports right on TradingView.
QIAGEN NV is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
QGE3 earnings for the last quarter are 0.59 EUR per share, whereas the estimation was 0.60 EUR resulting in a −1.02% surprise. The estimated earnings for the next quarter are 0.46 EUR per share. See more details about QIAGEN NV earnings.
QIAGEN NV revenue for the last quarter amounts to 503.27 M EUR, despite the estimated figure of 503.32 M EUR. In the next quarter, revenue is expected to reach 432.08 M EUR.
QGE3 net income for the last quarter is 85.32 M EUR, while the quarter before that showed 88.07 M EUR of net income which accounts for −3.12% change. Track more QIAGEN NV financial stats to get the full picture.
QIAGEN NV dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 15, 2025, the company has 5.76 K employees. See our rating of the largest employees — is QIAGEN NV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QIAGEN NV EBITDA is 674.47 M EUR, and current EBITDA margin is 35.30%. See more stats in QIAGEN NV financial statements.
Like other stocks, QGE3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QIAGEN NV stock right from TradingView charts — choose your broker and connect to your account.